PSTV
Price
$0.30
Change
-$0.01 (-3.23%)
Updated
Jul 3 closing price
Capitalization
15.12M
SBMFF
Price
$0.68
Change
-$0.01 (-1.45%)
Updated
Jul 2 closing price
Capitalization
12.43B
Interact to see
Advertisement

PSTV vs SBMFF

Header iconPSTV vs SBMFF Comparison
Open Charts PSTV vs SBMFFBanner chart's image
Plus Therapeutics
Price$0.30
Change-$0.01 (-3.23%)
Volume$4.14M
Capitalization15.12M
Sino Biopharmaceutical
Price$0.68
Change-$0.01 (-1.45%)
Volume$13.81K
Capitalization12.43B
PSTV vs SBMFF Comparison Chart in %
Loading...
PSTV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SBMFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PSTV vs. SBMFF commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PSTV is a Hold and SBMFF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (PSTV: $0.30 vs. SBMFF: $0.68)
Brand notoriety: PSTV and SBMFF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PSTV: 13% vs. SBMFF: 514%
Market capitalization -- PSTV: $15.12M vs. SBMFF: $12.43B
PSTV [@Biotechnology] is valued at $15.12M. SBMFF’s [@Biotechnology] market capitalization is $12.43B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PSTV’s FA Score shows that 0 FA rating(s) are green whileSBMFF’s FA Score has 2 green FA rating(s).

  • PSTV’s FA Score: 0 green, 5 red.
  • SBMFF’s FA Score: 2 green, 3 red.
According to our system of comparison, SBMFF is a better buy in the long-term than PSTV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PSTV’s TA Score shows that 6 TA indicator(s) are bullish while SBMFF’s TA Score has 2 bullish TA indicator(s).

  • PSTV’s TA Score: 6 bullish, 2 bearish.
  • SBMFF’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, PSTV is a better buy in the short-term than SBMFF.

Price Growth

PSTV (@Biotechnology) experienced а -19.15% price change this week, while SBMFF (@Biotechnology) price change was -1.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

PSTV is expected to report earnings on May 30, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SBMFF($12.4B) has a higher market cap than PSTV($15.1M). SBMFF YTD gains are higher at: 65.913 vs. PSTV (-74.226). SBMFF has higher annual earnings (EBITDA): 6.98B vs. PSTV (-22.17M). SBMFF has higher revenues than PSTV: SBMFF (26.2B) vs PSTV (0).
PSTVSBMFFPSTV / SBMFF
Capitalization15.1M12.4B0%
EBITDA-22.17M6.98B-0%
Gain YTD-74.22665.913-113%
P/E RatioN/A46.62-
Revenue026.2B-
Total Cash9.87MN/A-
Total Debt40KN/A-
FUNDAMENTALS RATINGS
PSTV vs SBMFF: Fundamental Ratings
PSTV
SBMFF
OUTLOOK RATING
1..100
3182
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
2
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
9636
P/E GROWTH RATING
1..100
1009
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SBMFF's Valuation (2) in the null industry is somewhat better than the same rating for PSTV (46). This means that SBMFF’s stock grew somewhat faster than PSTV’s over the last 12 months.

SBMFF's Profit vs Risk Rating (100) in the null industry is in the same range as PSTV (100). This means that SBMFF’s stock grew similarly to PSTV’s over the last 12 months.

SBMFF's SMR Rating (97) in the null industry is in the same range as PSTV (100). This means that SBMFF’s stock grew similarly to PSTV’s over the last 12 months.

SBMFF's Price Growth Rating (36) in the null industry is somewhat better than the same rating for PSTV (96). This means that SBMFF’s stock grew somewhat faster than PSTV’s over the last 12 months.

SBMFF's P/E Growth Rating (9) in the null industry is significantly better than the same rating for PSTV (100). This means that SBMFF’s stock grew significantly faster than PSTV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PSTVSBMFF
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
56%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
66%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
47%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
54%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
61%
Advances
ODDS (%)
Bullish Trend 9 days ago
83%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
72%
Aroon
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 2 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
PSTV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SBMFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
KAUG25.180.13
+0.50%
Innovator U.S. Small Cp Pwr Buf ETF -Aug
DOL59.780.09
+0.15%
WisdomTree International LargeCp Div ETF
XHYF37.85N/A
N/A
BondBloxx US Hg Yld Fncl & REIT Str ETF
SRHQ36.55N/A
N/A
SRH U.S. Quality GARP ETF
SPSB30.04-0.02
-0.07%
SPDR® Portfolio Short Term Corp Bd ETF

SBMFF and

Correlation & Price change

A.I.dvisor tells us that SBMFF and PSTV have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SBMFF and PSTV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SBMFF
1D Price
Change %
SBMFF100%
N/A
PSTV - SBMFF
22%
Poorly correlated
-3.52%
BCDA - SBMFF
21%
Poorly correlated
+6.00%
INKT - SBMFF
21%
Poorly correlated
+0.86%
ALZN - SBMFF
20%
Poorly correlated
-2.00%
LYEL - SBMFF
20%
Poorly correlated
+2.76%
More